Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Kidney transplant patients who develop diabetes show poor short-term outcomes

24.02.2004


Patients who develop diabetes shortly after kidney transplantation have poorer short-term outcomes than those who had the disease before transplant, according to a Penn State Milton S. Hershey Medical Center study.



"Because patients with diabetes often pose many medical challenges due to the complications of the disease, it was surprising to see that these patients who’d been dealing with diabetes for years, ended up better off than the patients who only developed diabetes after their transplants," said Robert Gabbay, M.D., Ph.D., associate professor of medicine, co-director, Penn State Diabetes Center, and principal investigator of the study, which appeared in the December 2003 issue of Transplantation Proceedings. "Overall, patients who developed post-transplant diabetes were most vulnerable to kidney rejection, infection and additional hospitalization."

The study included 181 kidney transplant patients at Penn State Milton S. Hershey Medical Center from January 1999 to December 2000. The patients were divided into three groups: those who had diabetes prior to kidney transplant, those who developed diabetes mellitus within 24 weeks after transplant; and those who did not have diabetes mellitus before or after transplant. Data was collected before and after the patients’ transplants.


Results showed that about 22 percent of previously non-diabetic patients developed post-transplant diabetes within six months of kidney transplant. About 57 percent of those patients developed an infection compared to 35 percent of patients who had diabetes prior to transplant and 21 percent of patients who did not have or develop diabetes. Patients who developed post-transplant diabetes also were more likely to have recurrent infections than the other two patient groups.

"We would expect that patients who were recently diagnosed with diabetes wouldn’t yet be suffering from complications, yet our study showed that they do have poorer kidney transplant outcomes," Gabbay said.

Although few in number, previous long-term studies showed that the standard post-transplant drug therapies taken to help patients avoid organ rejection can actually cause patients to develop diabetes. Limited data form other studies also has suggested that post-transplant diabetes is associated with higher rates of long-term sickness and death primarily due to an increase in infections or heart and vascular problems.

"This study focused on the first six months after transplant because short term rehospitalization is a great concern for transplant patients," Gabbay said. "If bad outcomes start early, then earlier interventions may be helpful for the long-term health of the patients." Gabbay said the health information presented in the long-term outcomes studies may include influences from other medical complications of diabetes. Focusing on the short term may remove any influences from the long-term complications of diabetes and allow the researchers to focus on the glucose values. Tight control of glucose, or blood sugar, with the use of insulin is important for all patients with diabetes to remain healthy.

"We believe that the poor outcomes in those who develop diabetes after kidney transplant may have something to do with glucose levels and we plan to study that next," Gabbay said. "We hope that medical interventions early could lead to better outcomes for these patients in the long run."

Co-authors on the study were: T.F.M. Saleem, M.D., fellow; K.E. Cunningham, medical student, Penn State College of Medicine, C.S. Hollenbeak, Ph.D., assistant professor of surgery and health evaluation sciences; and E. J. Alfrey, M.D., professor of surgery, Penn State College of Medicine, Penn State Hershey Medical Center.


Penn State Diabetes Center is a partnership of scientists and medical specialists whose continued goal is to increase the scientific and medical knowledge needed to eradicate diabetes, and help those with diabetes to live better, healthier lives. Penn State Diabetes Center is piloting a new integrated system – the first of its kind in Pennsylvania and only the second in the nation – to help primary care physicians to make sure that patients with diabetes are getting all of the recommended screenings and tests.

Valerie Gliem | EurekAlert!
Further information:
http://www.psu.edu/

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>